Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Sep 22;1(21):1839-1841.
doi: 10.1182/bloodadvances.2017011031. eCollection 2017 Sep 26.

Treatment and relative survival in very elderly patients with DLBCL in The Netherlands: a population-based study, 1989 to 2015

Avinash G Dinmohamed  1   2   3 , Djamila E Issa  4 , Marjolein W M van der Poel  5 , Harry C Schouten  5 , Pieternella J Lugtenburg  3 , Martine E D Chamuleau  6 , Sonja Zweegman  6 , Otto Visser  7
Affiliations
Comment

Treatment and relative survival in very elderly patients with DLBCL in The Netherlands: a population-based study, 1989 to 2015

Avinash G Dinmohamed et al. Blood Adv. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: The authors declare no competing financial interests.

Figures

Figure 1.
Figure 1.
RS of very elderly patients with DLBCL in The Netherlands according to period of diagnosis and age at diagnosis from 1989 to 2015. RS rates (RSRs) are shown for the following age categories: 80 to 84 (A), 85 to 89 (B), and ≥90 years (C). The tables present the projected 1-, 3-, and 5-year RSRs with 95% confidence intervals (CIs) according to period of diagnosis. Additionally, the OS in the patient cohort and the expected survival of an equivalent group from the general population, matched to the patients with respect to age, sex, and period, are plotted in supplemental Figure 2 to provide readers an enhanced understanding of the dynamics of RS. *P value for likelihood ratio test assessing linear trends from the period of 1989 to 2002 to the period of 2008 to 2015.
See this image and copyright information in PMC

Comment on

References

    1. Giri U, Martin MG. Survival outcomes in the very elderly with DLBCL prior to and after the introduction of rituximab: a US population-based study. Blood Adv. 2017;1(10):615-618. - PMC - PubMed
    1. Dickman PW, Adami HO. Interpreting trends in cancer patient survival. J Intern Med. 2006;260(2):103-117. - PubMed
    1. Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med. 2004;23(1):51-64. - PubMed

LinkOut - more resources